Clinical Trials Logo

Nervous System Neoplasms clinical trials

View clinical trials related to Nervous System Neoplasms.

Filter by:

NCT ID: NCT00003476 Recruiting - Clinical trials for Brain and Central Nervous System Tumors

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Start date: March 1996
Phase: Phase 2
Study type: Interventional

RATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating children with primary malignant brain tumors.

NCT ID: NCT00003475 Recruiting - Clinical trials for Brain and Central Nervous System Tumors

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Start date: February 1996
Phase: Phase 2
Study type: Interventional

RATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with primary malignant brain tumors.

NCT ID: NCT00003470 Recruiting - Clinical trials for Brain and Central Nervous System Tumors

Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma

Start date: March 1996
Phase: Phase 2
Study type: Interventional

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with anaplastic astrocytoma that has not responded to previous treatment.

NCT ID: NCT00003457 Recruiting - Clinical trials for Brain and Central Nervous System Tumors

Antineoplaston Therapy in Treating Patients With Brain Tumors

Start date: July 1996
Phase: Phase 2
Study type: Interventional

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with brain tumors.

NCT ID: NCT00002647 Recruiting - Metastatic Cancer Clinical Trials

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Start date: May 1994
Phase: Phase 1
Study type: Interventional

RATIONALE: Photodynamic therapy uses light and photosensitizing drugs to kill tumor cells and may be an effective treatment for refractory brain tumors. PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic therapy using porfimer sodium in treating patients with refractory brain tumors, including astrocytoma, ependymoma, and medulloblastoma.